H. Tashiro and T. Okubo, Distribution of cadmium, copper and zinc in human liver and kidney, Biomed. Res. Trace Elements
13(1), 56–64 (2002).
U. B. Dogan, M. Cindoruk, S. Dumlu, et al., Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma, Ital. J. Gastroenterol. Hepatol.
, 476 (1997).PubMed
N. Nagasue, H. Kohno, Y. Chang, et al., Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma, Oncology
, 293–296 (1989).PubMed
G. N. Schrauzer, Selenium and breast cancer, J. Am. Med. Assoc.
), 28 (1991).CrossRef
F. Nomura and K. Takekoshi, Zinc and selenium metabolism in liver cirrhosis, Jpn. J. Clin. Med.
52(1), 165–169 (1994) (in Japanese).
B. L. Vallee, W.E.C. Wacker, A. E. Bartholomay, et al., Zinc metabolism in hepatic dysfunction, Ann. Intern. Med.
, 1077–1091 (1959).PubMed
M. F. Rodriguez, R. E. Gonzalez, F. F. Santolaria, et al., Zinc, copper, manganese, and iron in chronic alcoholic liver disease, Alcohol
), 39–44 (1997).CrossRef
J. Solis-Herruzo, B. De-Cuenca, and M. C. Munoz-Rivero, Intestinal zinc absorption in cirrhotic patients, J. Gastroenterol.
27, 335–338 (1989).
K. Suzuki, R. Oyama, E. Hayashi, and Y. Arakawa, Liver diseases and essential trace elements, Nippon Rinsho
), 85–92 (1996) (in Japanese).PubMed
S. Takikawa, Changes in serum Zn, Cu, Se, and Mn levels in patients with chronic liver diseases and hepatocellular carcinoma, J. Clin. Biochem. Nutr.
8, 153–164 (1990).
Y. Mimata, S. Ujiie, T. Himori, and A. Wakui, Serum copper and the copper: zinc ratio in patients with gastric cancer, Jpn. J. Cancer Clin.
32(12), 1533–1539 (1986) (in Japanese).
H. Tashiro, Unpublished data.
S. Chen, Hypozincemia in compensated cirrhotic patients, Yokohama Med. J.
42, 307–314 (1991) (in Japanese).
W. DeWys and W. Pories, Inhibition of a spectrum of animal tumors by dietary zinc deficiency, J. Natl. Cancer. Inst.
, 375–381 (1972).PubMed
J. L. Phillips and P. J. Sheridan, Effect of zinc administration on growth of L1210 and BW5147 tumors in mice, J. Natl. Cancer. Inst.
, 361–363 (1976).PubMed
C. J. McClain, L. Adams, and S. Shedlofsky, Zinc and the gastrointestinal system, in Essential and Toxic Elements in Health and Disease, A. S. Prasad, ed., Liss, New York, pp. 55–73 (1988).
K. Griffith, E. B. Wright, and T. L. Dormandy, Tissue zinc in malignant disease, Nature
, 60 (1973).PubMedCrossRef
M. C. Kew and R. C. Mallett, Hepatic zinc concentrations in primary cancer of liver, Br. J. Cancer
, 80–83 (1974).PubMed
S. Ujiie, Y. Itoh, H. Kikuchi, and A. Wakui, Zinc distribution in malignant tumors, Biomed. Res. Trace Elements
6(1), 45–50 (1995).
Y. Yazaki, Hepatic copper concentrations in various liver diseases, Acta Hepatol. Japon.
25(10), 34–46 (1984) (in Japanese).
I. Sternlieb, Copper and the liver, Gastroenterology
, 1615–1628 (1980).PubMed
H. S. Dang and S. Somasundaran, Copper levels in Indian childhood cirrhosis, Lancet
ii, 246 (1979).
M. Diez, F. J. Cerdan, M. Arroyo, and J. L. Balibrea, Use of the copper/zinc ratio in the diagnosis of lung cancer, Cancer
, 726–730 (1989).PubMedCrossRef
J. A. Garofalo, H. Ashikari, M. L. Lesser, et al., Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions, Cancer
, 2682–2685 (1980).PubMedCrossRef
I. Shah-Reddy, P. Khilanani, and C. R. Bishop, Serum copper levels in non-Hodgkin’s lymphoma, Cancer
, 2156–2159 (1980).PubMedCrossRef
O. Miatto, M. Casaril, G. B. Gabrielli, N. Nicoli, G. Bellisola, and R. Corrocher, Diagnostic and prognostic value of serum copper and plasma fibrinogen in hepatic carcinoma, Cancer
, 774–778 (1985).PubMedCrossRef
Y. Arakawa, K. Suzuki, K. Suzuki, Y. Matsuo, and S. Takeuchi, Liver diseases and trace elements, Saishin-Igaku
4, 668–677 (1990) (in Japanese).
A. Ozawa, Y. Hatta, and G. Matsumura, Studies on human hepatic copper contents in Japanese patients with liver cirrhosis, J. Jpn. Soc. Intern. Med.
73(7), 925–934 (1984) (in Japanese).
H. Oyama, Trace elements: mechanistic aspects of anticararcinogenic action, Nippon Rinsho
54(1), 52–58 (1996) (in Japanese).
J. T. Salone, G. Alfthan, J. K. Huttunen, and P. Puska, Association between serum selenium and the risk of cancer, Am. J. Epidemiol.
120, 342–349 (1984).
W. C. Willett, B. F. Polk, J. S. Morris, et al., Prediagnostic serum selenium and risk of cancer, Lancet
, 130–134 (1983).CrossRef
S. Y. Yu, Y. J. Zhu, and W. G. Li, Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong, Biol. Trace Element Res.
56, 117–124 (1997).
S. Y. Yu, P. Ao, L. M. Wang, et al., Biochemical and cellular aspects of the anticancer activity of selenium, Biol. Trace Element Res.
15, 243–255 (1988).
D. Kromhout, Essential micronutrients in relation to carcinogenesis, Am. J. Clin. Nutr.
, 1361–1367 (1987).PubMed
M. Kabuto, H. Imai, C. Yonezawa, et al., Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan, Cancer Epidemiol. Biomarkers Prev.
, 465–469 (1994).PubMed
T. Yazaki, T. Iizumi, H. Tomomasa, H. Amemiya, and S. Oshio, Study of multi-elements in renal cancer tissue, Nishinihon J. Urol.
51(5), 1475–1479 (1989) (in Japanese).
A. Feustel, R. Wennrich, and M. Dittrich, Studies of Cd, Zn and Cu levels in human kidney tumours and normal kidney, Urol. Res.
, 105–108 (1986).PubMedCrossRef
Z. A. Karcioglu, R. M. Sarper, H. A. Van Rinsvelt, J. A. Guffey, and R. W. Fink, Trace element concentrations in renal cell carcinoma, Cancer
, 1330–1340 (1978).PubMedCrossRef
Y. Deugnier and B. Turlin, Iron and hepatocellular carcinoma, J. Gastroenterol. Hepatol.
), 491–494 (2001).PubMedCrossRef
C.E.G. Robinson, D. N. Bell, and J. H. Sturdy, Possible association of malignant neoplasma with iron-dextran. A case report, Br. Med. J.
27, 648–650 (1960).
A. E. MacKinnon and J. Bancewicz, Sarcoma after injection of intramuscular iron, Br. Med. J.
, 277–279 (1973).CrossRef
T. H. Bothwell, and C. Isaacson, Siderosis in the Bantu: a comparison of the incidence in males and females, Br. Med. J.
24, 522–524 (1962).
T. Oyama, K. Matsuno, T. Kawamoto, T. Mitsudomi, T. Shirakusa, and Y. Kodama, Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer, Biol. Trace Element Res.
42, 115–127 (1994).